ACCURAY INC (ARAY) Stock Fundamental Analysis
USA - NASDAQ:ARAY - US0043971052 - Common Stock
1.67 USD
0 (0%)
1.66 USD
-0.01 (-0.6%)
ARAY gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 190 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of ARAY while its profitability can be described as average. ARAY is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year ARAY has reported negative net income.
In the past year ARAY had a positive cash flow from operations.
ARAY had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: ARAY reported negative operating cash flow in multiple years.
1.2 Ratios
The Return On Assets of ARAY (0.14%) is better than 71.58% of its industry peers.
With a decent Return On Equity value of 1.36%, ARAY is doing good in the industry, outperforming 72.63% of the companies in the same industry.
ARAY has a better Return On Invested Capital (2.93%) than 71.58% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ARAY is significantly below the industry average of 8.43%.
The 3 year average ROIC (1.28%) for ARAY is below the current ROIC(2.93%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.14% | ||
| ROE | 1.36% | ||
| ROIC | 2.93% |
ROA(3y)-1.87%
ROA(5y)-1.61%
ROE(3y)-17.92%
ROE(5y)-14.58%
ROIC(3y)1.28%
ROIC(5y)2.47%
1.3 Margins
ARAY has a better Profit Margin (0.14%) than 72.11% of its industry peers.
ARAY has a better Operating Margin (2.24%) than 67.37% of its industry peers.
ARAY's Operating Margin has declined in the last couple of years.
ARAY's Gross Margin of 31.48% is on the low side compared to the rest of the industry. ARAY is outperformed by 75.26% of its industry peers.
In the last couple of years the Gross Margin of ARAY has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.24% | ||
| PM (TTM) | 0.14% | ||
| GM | 31.48% |
OM growth 3Y-3.19%
OM growth 5Y-12.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.86%
GM growth 5Y-3.89%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ARAY is destroying value.
ARAY has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ARAY has more shares outstanding
Compared to 1 year ago, ARAY has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.11, we must say that ARAY is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.11, ARAY perfoms like the industry average, outperforming 45.79% of the companies in the same industry.
ARAY has a debt to FCF ratio of 9.13. This is a negative value and a sign of low solvency as ARAY would need 9.13 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 9.13, ARAY is doing good in the industry, outperforming 74.74% of the companies in the same industry.
A Debt/Equity ratio of 3.35 is on the high side and indicates that ARAY has dependencies on debt financing.
ARAY's Debt to Equity ratio of 3.35 is on the low side compared to the rest of the industry. ARAY is outperformed by 87.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.35 | ||
| Debt/FCF | 9.13 | ||
| Altman-Z | 0.11 |
ROIC/WACC0.43
WACC6.89%
2.3 Liquidity
ARAY has a Current Ratio of 1.64. This is a normal value and indicates that ARAY is financially healthy and should not expect problems in meeting its short term obligations.
ARAY's Current ratio of 1.64 is on the low side compared to the rest of the industry. ARAY is outperformed by 71.58% of its industry peers.
ARAY has a Quick Ratio of 1.64. This is a bad value and indicates that ARAY is not financially healthy enough and could expect problems in meeting its short term obligations.
ARAY has a worse Quick ratio (0.92) than 81.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.64 | ||
| Quick Ratio | 0.92 |
3. Growth
3.1 Past
ARAY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 81.88%, which is quite impressive.
ARAY shows a small growth in Revenue. In the last year, the Revenue has grown by 2.68%.
ARAY shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.67% yearly.
EPS 1Y (TTM)81.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-96.67%
Revenue 1Y (TTM)2.68%
Revenue growth 3Y2.17%
Revenue growth 5Y3.67%
Sales Q2Q%-5.02%
3.2 Future
ARAY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 53.35% yearly.
Based on estimates for the next years, ARAY will show a small growth in Revenue. The Revenue will grow by 4.26% on average per year.
EPS Next Y-5.52%
EPS Next 2Y53.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.62%
Revenue Next 2Y4.26%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
ARAY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ARAY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
76.84% of the companies in the same industry are more expensive than ARAY, based on the Enterprise Value to EBITDA ratio.
96.32% of the companies in the same industry are more expensive than ARAY, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.89 | ||
| EV/EBITDA | 17.24 |
4.3 Compensation for Growth
ARAY's earnings are expected to grow with 53.35% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y53.35%
EPS Next 3YN/A
5. Dividend
5.1 Amount
ARAY does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
1.67
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners71.34%
Inst Owner Change27.08%
Ins Owners1.77%
Ins Owner Change-0.06%
Market Cap188.18M
Analysts86
Price Target5.61 (235.93%)
Short Float %2.02%
Short Ratio2.96
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)129.41%
Min EPS beat(2)80.39%
Max EPS beat(2)178.43%
EPS beat(4)4
Avg EPS beat(4)72.77%
Min EPS beat(4)6.95%
Max EPS beat(4)178.43%
EPS beat(8)5
Avg EPS beat(8)-66.07%
EPS beat(12)8
Avg EPS beat(12)-37.55%
EPS beat(16)11
Avg EPS beat(16)-21.51%
Revenue beat(2)2
Avg Revenue beat(2)6.28%
Min Revenue beat(2)3.2%
Max Revenue beat(2)9.35%
Revenue beat(4)4
Avg Revenue beat(4)5.74%
Min Revenue beat(4)2.05%
Max Revenue beat(4)9.35%
Revenue beat(8)5
Avg Revenue beat(8)1.04%
Revenue beat(12)8
Avg Revenue beat(12)1.33%
Revenue beat(16)11
Avg Revenue beat(16)2.63%
PT rev (1m)29.41%
PT rev (3m)29.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)333.33%
EPS NY rev (1m)0%
EPS NY rev (3m)72.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.53%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.4 | ||
| P/FCF | 9.89 | ||
| P/OCF | 8.38 | ||
| P/B | 3.8 | ||
| P/tB | N/A | ||
| EV/EBITDA | 17.24 |
EPS(TTM)-0.03
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)0.17
FCFY10.11%
OCF(TTM)0.2
OCFY11.93%
SpS4.13
BVpS0.44
TBVpS-0.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.14% | ||
| ROE | 1.36% | ||
| ROCE | 3.71% | ||
| ROIC | 2.93% | ||
| ROICexc | 4.06% | ||
| ROICexgc | 6.27% | ||
| OM | 2.24% | ||
| PM (TTM) | 0.14% | ||
| GM | 31.48% | ||
| FCFM | 4.09% |
ROA(3y)-1.87%
ROA(5y)-1.61%
ROE(3y)-17.92%
ROE(5y)-14.58%
ROIC(3y)1.28%
ROIC(5y)2.47%
ROICexc(3y)1.68%
ROICexc(5y)3.79%
ROICexgc(3y)2.32%
ROICexgc(5y)5.59%
ROCE(3y)1.61%
ROCE(5y)3.13%
ROICexcg growth 3Y-10.78%
ROICexcg growth 5Y-10.94%
ROICexc growth 3Y-7.95%
ROICexc growth 5Y-10.33%
OM growth 3Y-3.19%
OM growth 5Y-12.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.86%
GM growth 5Y-3.89%
F-Score6
Asset Turnover0.96
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.35 | ||
| Debt/FCF | 9.13 | ||
| Debt/EBITDA | 10.08 | ||
| Cap/Depr | 56.4% | ||
| Cap/Sales | 0.73% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 136.22% | ||
| Profit Quality | 2828.08% | ||
| Current Ratio | 1.64 | ||
| Quick Ratio | 0.92 | ||
| Altman-Z | 0.11 |
F-Score6
WACC6.89%
ROIC/WACC0.43
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)81.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-96.67%
EPS Next Y-5.52%
EPS Next 2Y53.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.68%
Revenue growth 3Y2.17%
Revenue growth 5Y3.67%
Sales Q2Q%-5.02%
Revenue Next Year4.62%
Revenue Next 2Y4.26%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y346.62%
EBIT growth 3Y-1.09%
EBIT growth 5Y-8.91%
EBIT Next Year166.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y179.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y273.95%
OCF growth 3YN/A
OCF growth 5YN/A